Regulatory Actions
Sciele Pharma Submits Supplemental New Drug Application to FDA for New Sular Formulation
Published in Medical Letter on the CDC and FDA, July 22nd, 2007
Keywords: Drugs, FDA, Nisoldipine, Pharmaceuticals, Regulatory Actions, Sular, Therapy, Treatment, U.S. Food and Drug Administration, Sciele Pharma.
This article was prepared by Medical Letter on the CDC & FDA editors from staff and other reports. Copyright 2007, Medical Letter on the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Cancer Vaccines
Human antibodies that block human and animal SARS viruses identified - Depression
Antidepressant warnings associated with decreased prescription rates among Tennessee children - Pandemic
Scientists describe how 1918 influenza virus sample was exhumed in Alaska - Psychotherapy
Suicide attempts decline after depression treatment - Adverse Drug Reactions
Spectranetics Receives FDA Clearance to Market TURBO-Booster - Allergies
FDA Advice: What You Need to Know About Food Allergies - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
